Related Experiment Video
Updated: Jun 3, 2026

Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
Published on: May 17, 2014
Activation of mTORC2 by association with the ribosome
Vittoria Zinzalla1, Daniele Stracka, Wolfgang Oppliger
1Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
Abstract:
The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of growth. Mammalian TOR complex 2 (mTORC2) regulates AGC kinase family members and is implicated in various disorders, including cancer and diabetes. Here, we investigated the upstream regulation of mTORC2. A genetic screen in yeast and subsequent studies in mammalian cells revealed that ribosomes, but not protein synthesis, are required for mTORC2 signaling. Active mTORC2 was physically associated with the ribosome, and insulin-stimulated PI3K signaling promoted mTORC2-ribosome binding, suggesting that ribosomes activate mTORC2 directly. Findings with melanoma and colon cancer cells suggest that mTORC2-ribosome association is important in oncogenic PI3K signaling. Thus, TORC2-ribosome interaction is a likely conserved mechanism of TORC2 activation that is physiologically relevant in both normal and cancer cells. As ribosome content determines growth capacity of a cell, this mechanism of TORC2 regulation ensures that TORC2 is active only in growing cells.
Insights
Ribosomes, not protein synthesis, are essential for mammalian target of rapamycin complex 2 (mTORC2) signaling. This conserved mTORC2-ribosome interaction is crucial for cell growth and cancer progression.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The target of rapamycin (TOR) pathway is a central regulator of cell growth and metabolism.
- Mammalian TOR complex 2 (mTORC2) controls AGC kinases and is involved in diseases like cancer and diabetes.
- Upstream regulators of mTORC2 activity remain incompletely understood.
Purpose of the Study:
- To elucidate the upstream regulatory mechanisms of mTORC2 signaling.
- To investigate the role of ribosomes and protein synthesis in mTORC2 activation.
- To determine the physiological relevance of mTORC2 regulation in normal and cancer cells.
Main Methods:
- Genetic screening in yeast.
- Studies in mammalian cell lines, including melanoma and colon cancer cells.
- Analysis of mTORC2-ribosome association and PI3K signaling.
Main Results:
- Ribosomes, but not protein synthesis, are required for mTORC2 signaling.
- Active mTORC2 physically associates with ribosomes.
- Insulin-stimulated PI3K signaling enhances mTORC2-ribosome binding.
- mTORC2-ribosome association is vital in oncogenic PI3K signaling in cancer cells.
Conclusions:
- Ribosomes directly activate mTORC2.
- mTORC2-ribosome interaction is a conserved mechanism for mTORC2 activation.
- This regulatory mechanism ensures mTORC2 activity is linked to cellular growth capacity.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Directing Proteins to the Rough Endoplasmic Reticulum

